-- 安徽丰源药业（深交所代码：000153）的复合聚乙二醇电解质粉剂已获得中国国家药品监督管理总局的药品注册。 根据周五提交给深圳证券交易所的文件，该处方粉剂适用于治疗儿童慢性便秘。 该批准有效期至2031年4月28日。 该公司股价周五收盘上涨1%。
Related Articles
Asia
Jefferies Adjusts Tokyo Electron's Price Target to 59,000 Yen From 48,000 Yen, Keeps at Buy
Tokyo Electron (TYO:8035) has an average rating of overweight and mean price target of 51,813.64 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$TYO:8035
Asia
Singapore-listed Aspial Corp Buys Back More Shares
Aspial Corp. (SGX:A30) bought back 400,000 shares in the open market on Friday for SG$59,454.According to a same-day filing with the Singapore Exchange, the jewelry and real estate company has bought back 1,150,000 shares since its mandate of daily share repurchases started April 28.
$SGX:A30
Asia
Jefferies Adjusts Blue Star's Price Target to INR1,735 From INR1,665, Keeps at Hold
Blue Star (NSE:BLUESTARCO, BOM:500067) has an average rating of hold and mean price target of 1,836.04 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$BOM:500067$NSE:BLUESTARCO